There have been 50 recent insider transactions recorded for Atrium Therapeutics, Inc. (RNA), including 17 buys and 29 sells. Total insider buying was valued at $16.86M and total insider selling at $8.27M.
Notable insiders with recent activity include Gallagher Kathleen P., Flanagan W. Michael, Levin Arthur A. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — RNA
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-06-17 |
Gallagher Kathleen P. |
Chief Program Officer |
Informative Sell |
911 |
$30.24 |
$27.55K |
50,392 |
| 2025-06-11 |
Flanagan W. Michael |
Chief Scientific Officer |
Informative Sell |
20,000 |
$32.88 |
$657.69K |
80,195 |
| 2025-06-10 |
Levin Arthur A |
Director |
RSU Award |
10,034 |
$33.62 |
$337.34K |
10,034 |
| 2025-06-10 |
Boess Carsten |
Director |
RSU Award |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Kaye Edward M. Md |
Director |
RSU Award |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Wilson Troy Edward |
Director |
RSU Award |
10,034 |
$33.62 |
$337.34K |
10,034 |
| 2025-06-10 |
Henig Noreen |
Director |
RSU Award |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Thompson Tamar |
Director |
RSU Award |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Kim Jean Jinsun |
Director |
RSU Award |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Skerjanec Simona |
Director |
RSU Award |
6,692 |
- |
- |
6,692 |
| 2025-06-02 |
Gallagher Kathleen P. |
Chief Program Officer |
Option Exercise (Sell) |
5,875 |
$16.65 |
$97.82K |
22,596 |
| 2025-05-01 |
Gallagher Kathleen P. |
Chief Program Officer |
Option Exercise (Sell) |
5,875 |
$16.65 |
$97.82K |
28,471 |
| 2025-04-01 |
Gallagher Kathleen P. |
Chief Program Officer |
Option Exercise (Sell) |
5,546 |
$14.70 |
$81.53K |
13,829 |
| 2025-03-20 |
Maclean Michael F |
Chief Financial Officer |
Informative Sell |
7,935 |
$31.06 |
$246.42K |
96,720 |
| 2025-03-20 |
Boyce Sarah |
President and CEO |
Informative Sell |
31,540 |
$31.06 |
$979.56K |
305,871 |
| 2025-03-20 |
Hughes Steven George |
Chief Medical Officer |
Informative Sell |
9,578 |
$31.06 |
$297.49K |
72,850 |
| 2025-03-20 |
Flanagan W. Michael |
Chief Scientific Officer |
Informative Sell |
11,780 |
$31.06 |
$365.87K |
80,195 |
| 2025-03-20 |
Mccarthy Teresa |
Chief Human Resources Officer |
Informative Sell |
7,778 |
$31.06 |
$241.58K |
97,130 |
| 2025-03-11 |
Flanagan W. Michael |
Chief Scientific Officer |
Informative Sell |
20,000 |
$30.13 |
$602.61K |
91,975 |
| 2025-03-03 |
Gallagher Kathleen P. |
Chief Program Officer |
Option Exercise (Sell) |
5,875 |
$14.70 |
$86.36K |
19,375 |
| 2025-02-03 |
Gallagher Kathleen P. |
Chief Program Officer |
Option Exercise (Sell) |
5,875 |
$16.65 |
$97.82K |
34,675 |
| 2025-01-22 |
Gallagher Kathleen P. |
Chief Program Officer |
Informative Sell |
5,629 |
$30.16 |
$169.78K |
50,554 |
| 2025-01-21 |
Levin Arthur A |
Director |
Informative Sell |
1,872 |
$28.60 |
$53.54K |
12,958 |
| 2025-01-21 |
Maclean Michael F |
Chief Financial Officer |
Informative Sell |
1,665 |
$28.59 |
$47.61K |
104,655 |
| 2025-01-21 |
Boyce Sarah |
President and CEO |
Informative Sell |
5,659 |
$28.59 |
$161.82K |
337,411 |
| 2025-01-21 |
Hughes Steven George |
Chief Medical Officer |
Informative Sell |
2,032 |
$28.59 |
$58.1K |
82,428 |
| 2025-01-21 |
Flanagan W. Michael |
Chief Scientific Officer |
Informative Sell |
1,812 |
$28.59 |
$51.81K |
91,975 |
| 2025-01-21 |
Mccarthy Teresa |
Chief Human Resources Officer |
Informative Sell |
1,221 |
$28.60 |
$34.92K |
104,908 |
| 2025-01-21 |
Gallagher Kathleen P. |
Chief Program Officer |
Informative Sell |
1,817 |
$28.59 |
$51.95K |
56,183 |
| 2025-01-06 |
Maclean Michael F |
Chief Financial Officer |
RSU Award |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Moriarty John B |
Chief Legal Officer |
RSU Award |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Boyce Sarah |
President and CEO |
RSU Award |
165,000 |
$31.42 |
$5.18M |
165,000 |
| 2025-01-06 |
Mosbrooker Eric |
Chief Commercial Officer |
Unknown |
315,000 |
$9.05 |
$2.85M |
- |
| 2025-01-06 |
Mosbrooker Eric |
Chief Commercial Officer |
RSU Award |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Hughes Steven George |
Chief Medical Officer |
Unknown |
84,625 |
$15.96 |
$1.35M |
- |
| 2025-01-06 |
Hughes Steven George |
Chief Medical Officer |
RSU Award |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Flanagan W. Michael |
Chief Scientific Officer |
RSU Award |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Mccarthy Teresa |
Chief Human Resources Officer |
RSU Award |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Gallagher Kathleen P. |
Chief Program Officer |
Unknown |
16,000 |
$44.00 |
$704K |
- |
| 2025-01-06 |
Gallagher Kathleen P. |
Chief Program Officer |
RSU Award |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Calderaro Charles Iii |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-01-06 |
Calderaro Charles Iii |
Chief Technical Officer |
RSU Award |
40,000 |
- |
- |
40,000 |
| 2024-12-18 |
Maclean Michael F |
Chief Financial Officer |
Informative Sell |
11,151 |
$32.66 |
$364.19K |
82,942 |
| 2024-12-18 |
Boyce Sarah |
President and CEO |
Informative Sell |
31,855 |
$32.66 |
$1.04M |
265,308 |
| 2024-12-18 |
Flanagan W. Michael |
Csto |
Informative Sell |
12,742 |
$32.66 |
$416.15K |
72,647 |
| 2024-12-18 |
Mccarthy Teresa |
Chief Human Resources Officer |
Informative Sell |
11,151 |
$32.66 |
$364.19K |
82,867 |
| 2024-12-16 |
Mccarthy Teresa |
Chief Human Resources Officer |
Option Exercise (Sell) |
25,000 |
$14.22 |
$355.5K |
57,500 |
| 2024-12-11 |
Flanagan W. Michael |
Csto |
Informative Sell |
24,000 |
$35.77 |
$858.4K |
85,389 |
| 2024-11-19 |
Levin Arthur A |
Director |
Option Exercise (Sell) |
3,323 |
$1.24 |
$4.12K |
- |
| 2024-11-18 |
Mccarthy Teresa |
Chief Human Resources Officer |
Option Exercise (Sell) |
25,000 |
$14.22 |
$355.5K |
82,500 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
